234 related articles for article (PubMed ID: 3166463)
1. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells.
Owens GK; Geisterfer AA; Yang YW; Komoriya A
J Cell Biol; 1988 Aug; 107(2):771-80. PubMed ID: 3166463
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.
Grainger DJ; Kemp PR; Witchell CM; Weissberg PL; Metcalfe JC
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):227-35. PubMed ID: 8166645
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer AA; Peach MJ; Owens GK
Circ Res; 1988 Apr; 62(4):749-56. PubMed ID: 3280155
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.
Geisterfer AA; Owens GK
Hypertension; 1989 Oct; 14(4):413-20. PubMed ID: 2793215
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension.
Saltis J; Agrotis A; Bobik A
Am J Physiol; 1992 Aug; 263(2 Pt 1):C420-8. PubMed ID: 1514589
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells.
Blank RS; Thompson MM; Owens GK
J Cell Biol; 1988 Jul; 107(1):299-306. PubMed ID: 3392101
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II.
Koibuchi Y; Lee WS; Gibbons GH; Pratt RE
Hypertension; 1993 Jun; 21(6 Pt 2):1046-50. PubMed ID: 8505090
[TBL] [Abstract][Full Text] [Related]
8. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures.
Majack RA
J Cell Biol; 1987 Jul; 105(1):465-71. PubMed ID: 3475277
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor-beta 1 on growth of aortic smooth muscle cells. Influences of interaction with growth factors, cell state, cell phenotype, and cell cycle.
Morisaki N; Kawano M; Koyama N; Koshikawa T; Umemiya K; Saito Y; Yoshida S
Atherosclerosis; 1991 Jun; 88(2-3):227-34. PubMed ID: 1892488
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
[TBL] [Abstract][Full Text] [Related]
11. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.
Björkerud S
Arterioscler Thromb; 1991; 11(4):892-902. PubMed ID: 2065041
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
Gibbons GH; Pratt RE; Dzau VJ
J Clin Invest; 1992 Aug; 90(2):456-61. PubMed ID: 1644917
[TBL] [Abstract][Full Text] [Related]
14. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.
Assoian RK; Sporn MB
J Cell Biol; 1986 Apr; 102(4):1217-23. PubMed ID: 3457014
[TBL] [Abstract][Full Text] [Related]
15. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
Mikhail N; Fukuda N; Tremblay J; Hamet P
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest.
Reddy KB; Howe PH
J Cell Physiol; 1993 Jul; 156(1):48-55. PubMed ID: 8391008
[TBL] [Abstract][Full Text] [Related]
17. Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Roberts AB; Anzano MA; Wakefield LM; Roche NS; Stern DF; Sporn MB
Proc Natl Acad Sci U S A; 1985 Jan; 82(1):119-23. PubMed ID: 3871521
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat.
Owens GK; Schwartz SM
Circ Res; 1983 Oct; 53(4):491-501. PubMed ID: 6627608
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner.
Halloran BG; Prorok GD; So BJ; Baxter BT
Am J Surg; 1995 Aug; 170(2):193-7. PubMed ID: 7631929
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
